They demonstrated that co-treatment with Letrozole during gonadotropin stimulation was able to significantly decrease the incidence of OHSS compared to the control group receiving standard short GnRH therapy protocol and had reduced serum estrogen levels [26]. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.